Opioid use disorder is a medical condition where users have problematic patterns of opioid use that increases the risk of developing serious health problems. Opioid Agonist Treatment (OAT) – with methadone or buprenorphine – is the first-line treatment for those with an opioid use disorder.
Many patients receiving OAT must regularly attend specialized treatment clinics; however, it is unclear whether they are also able to access primary care services to ensure that they have appropriate screening and management of chronic diseases.
This study sought to determine if people receiving OAT are receiving high quality primary care.
Access the full article and associated resources: